Trading Woche
GSK, GB00BN7SWP63

GSK launches shingles campaign with Viola Davis; stock quoted at USD 46.54

Published on 10/09/2026 at 07:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK announced a new shingles education campaign with Viola Davis on October 8. The stock was quoted at USD 46.54 in after-hours trading that day.

Key points in brief

  • GSK announced a partnership with Viola Davis on October 8, 2026.
  • The campaign focuses on shingles risk among adults age 50 and older.
  • GSK was quoted at USD 46.54 on October 8, 2026, at 10:00 p.m. CEST.
Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht
GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK announced on October 8, 2026, that it had partnered with Viola Davis to launch the “Shingles, actually” disease education campaign. The stock was quoted at USD 46.54 on October 8, 2026, at 10:00 p.m. CEST.

Campaign targets adults age 50 and older

According to the PR Newswire release, the campaign is designed to encourage adults 50 and older to discuss shingles risk and prevention with doctors or pharmacists. Davis is sharing her experience with shingles as part of the initiative.

GSK statement

Rabab Pettitt, head of communications for U.S. Vaccines at GSK, said the campaign was shaped by insights from adults over 50 about health, aging and shingles prevention. The release identified GSK plc as the company behind the announcement.

Disclaimer...

en | GB00BN7SWP63 | GSK | boerse | 70271988 | bgmi